Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
Hyra Holdings launches $500M Hyra Combinator Fund to accelerate AI, fintech, and post-quantum security innovation, and confirms IPO roadmap targeting 2030.
Read More -
--- Ruxoprubart (NM8074) met all clinical endpoints, offering a safe, differentiated treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH). Paroxysmal Nocturnal Hemoglobinuria (PNH) is a...
Read More
-
Viva Gold to Present at the Precious Metals & Critical Metals Hybrid Investor Conference on May 22nd
VANCOUVER, British Columbia, May 19, 2025 (GLOBE NEWSWIRE) -- Viva Gold Corp (TSXV: VAU, OTCQB: VAUCF) (“Viva,” or the “Company”), the 100% owner and developer of the Tonopah Gold Project in Nevada,...
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
-- Initial positive data from Phase 1/2 clinical trial of PM359 in CGD provide clinical proof-of-concept for Prime Editing as a transformative gene editing technology -- -- On-track to file IND...
-
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Madison Realty Capital, a vertically integrated real estate private equity firm focused on real estate private credit, today announced that it has...
-
Delray Beach, FL, May 19, 2025 (GLOBE NEWSWIRE) -- Solar Tracker Market size is projected to grow from USD 10.32 billion in 2024 to USD 22.87 billion by 2029, at a CAGR of 17.3% according to a new...
-
Heaf Brings Proven Track Record of Driving Growth Across Iconic Global Consumer Brands Through Product, Retail, and Marketing Transformation Company Pre-Announces First Quarter 2025 Net Sales of $1.4...
-
Shenzhen, China, May 19, 2025 (GLOBE NEWSWIRE) -- Skillful Craftsman Education Technology Limited ("Skillful Craftsman" or the "Company") (NASDAQ: EDTK), a company focused on advancing technological...
-
-- First ever clinical data supporting safety and efficacy of Prime Editing in humans -- -- Initial data from first patient dosed in Phase 1/2 trial finds single dose of PM359 led to 58% DHR...
-
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to...
-
REalloys Inc., Signs Joint MOU with Saskatchewan Research Council Enabling Processing of Rare Earth Materials for High Performance Magnet Production